Astria Therapeutics Inc.

NASDAQ: ATXS · Real-Time Price · USD
6.85
0.09 (1.33%)
At close: Aug 15, 2025, 3:59 PM
6.85
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT

Astria Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-94.26M -72.89M -51.83M -194.91M
Depreciation & Amortization
n/a n/a n/a n/a
Stock-Based Compensation
13.04M 6.31M 4.55M 3.36M
Other Working Capital
1.74M -3.14M 3.41M -1.34M
Other Non-Cash Items
-4.54M 545K 1.1M 164.7M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
4.54M -2.41M 2.65M -3.31M
Operating Cash Flow
-81.21M -68.44M -43.53M -30.15M
Capital Expenditures
-325K -25K -91K -21K
Cash Acquisitions
n/a n/a 167.04K 6.47M
Purchase of Investments
-4.24B -1.92B -396.06M -78M
Sales Maturities Of Investments
4.05B 2.06B 229.03M 59M
Other Investing Acitivies
n/a n/a -167.04K n/a
Investing Cash Flow
-191.86M 135.05M -167.13M -12.55M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
4.79M 420K 84K 23K
Financial Cash Flow
157.2M 88.4M 144.72M 104.28M
Net Cash Flow
-115.87M 155M -65.94M 61.58M
Free Cash Flow
-81.54M -68.47M -43.62M -30.17M